DrugGen‑2 is a disease‑aware language model that designs small molecules by conditioning on both disease ontology and target protein sequences, thereby aligning molecular generation with therapeutic context. It builds on a fine‑tuned GPT‑2 model trained on a curated dataset. → View original source